Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.


BACKGROUND About one half of adults with acute lymphoblastic leukemia are not cured of the disease and ultimately die. The objective of this study was to explore the factors influencing the outcome of adult patients with relapsed acute lymphoblastic leukemia. DESIGN AND METHODS We analyzed the characteristics, the outcome and the prognostic factors for… (More)
DOI: 10.3324/haematol.2009.014274


5 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics